22157.jpg
Global Non-hormonal Therapies for Women's Health Market Report 2021-2030: Current Market Landscape with Focus on Prescription Drugs & Future Potential of this Evolving Market
20 juil. 2021 04h18 HE | Research and Markets
Dublin, July 20, 2021 (GLOBE NEWSWIRE) -- The "Non-hormonal Therapies for Women's Health Market by Target Indication, Type of Molecule, Purpose of Therapy, Mechanism of Action, Route of...
22157.jpg
Global Uterine Fibroids Clinical Landscape Market Report 2021 - Repros Therapeutics has the Highest Number of Completed Clinical Trials with 17
17 juin 2021 04h18 HE | Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Uterine Fibroids" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Uterine...
22157.jpg
Global Drug Forecast and Market Analysis for HER2-Negative Breast Cancer to 2028
09 nov. 2020 08h13 HE | Research and Markets
Dublin, Nov. 09, 2020 (GLOBE NEWSWIRE) -- The "HER2-Negative Breast Cancer: Global Drug Forecast and Market Analysis to 2028" report has been added to ResearchAndMarkets.com's offering. Human...
22157.jpg
Impact of COVID-19 on the Worldwide Industry for Progesterone to 2025
29 oct. 2020 09h43 HE | Research and Markets
Dublin, Oct. 29, 2020 (GLOBE NEWSWIRE) -- The "Progesterone Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology, Application" report...
MFB Fertility Launches Proov™, the First-Ever Home Progesterone Test for Fertility and Ovulation Tracking
26 oct. 2018 12h23 HE | MFB Fertility
BOULDER, Colo, Oct. 26, 2018 (GLOBE NEWSWIRE) -- MFB Fertility, Inc., a Boulder-based medical company created to empower women to know more about their reproductive health, today announced the...